Liver hormone secrets revealed: new study could reshape diabetes drugs
NCT ID NCT07300982
First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times
Summary
This study looks at how the hormone glucagon works with insulin in the liver to manage blood sugar. Researchers want to understand glucagon's multiple, sometimes opposite, roles to create better diabetes medicines. Forty healthy adults aged 18-45 will have two 5-hour sessions where they receive either glucagon or a saltwater solution while their blood sugar is kept steady. The goal is to learn how these hormones improve the liver's response to insulin.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES (DM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke Center for Living
Durham, North Carolina, 27705, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your bone health decide if a dental implant lasts?
- Ancient wisdom meets modern care: could chinese medicine boost diabetes Self-Management?
- Prescribing food: could a diet of medically tailored meals tame diabetes?
- Alexa, teach me about diabetes: smart speaker trial aims to improve blood sugar in older adults
- Do GLP-1 users skip strength training? new survey aims to find out
- Will a sticky patch stay put? study tests future pump design on kids